Taiwan FDA registration 68c40d99f1632eb274be12188f71ab79
Primus Ultra2 Variant Analyzer with Model 215 Auto-Sampler（Non-Sterile）
TW: 普林莫斯優特二型全自動化高壓液相層析儀（未滅菌）
Taiwan·Risk Class 1·MD·Trinity Biotech (Primus Corporation dba Trinity Biotech)·Registered Oct 01, 2021 – Oct 31, 2026ActiveRegistration details
- Analysis ID
- 68c40d99f1632eb274be12188f71ab79
- License Form
- Ministry of Health Medical Device Import Registration No. 003152
- Customs Code
- DHA08400315202
Company information
- Manufacturer Country
- United States
- Authorized Representative
- PROGRESSIVE GROUP INC.
Product details
- Intended Use
- A device that separates one or more drugs or compounds from a solution.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A2260 High pressure liquid chromatograph for clinical use
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 01, 2021
- Expiry Date
- Oct 31, 2026
About this record
Access comprehensive regulatory information for Primus Ultra2 Variant Analyzer with Model 215 Auto-Sampler（Non-Sterile） in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 68c40d99f1632eb274be12188f71ab79 and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices